\BOOKMARK [1][-]{section.1}{Summary}{}% 1
\BOOKMARK [1][-]{section.2}{Specific Aims}{}% 2
\BOOKMARK [1][-]{section.3}{Background and Significance}{}% 3
\BOOKMARK [2][-]{subsection.3.1}{Significance}{section.3}% 4
\BOOKMARK [2][-]{subsection.3.2}{Caenorhabditis elegans as a model organism}{section.3}% 5
\BOOKMARK [3][-]{subsubsection.3.2.1}{Quantitative genetics in Caenorhabditis elegans}{subsection.3.2}% 6
\BOOKMARK [3][-]{subsubsection.3.2.2}{Identifying genetic determinants that contribute to phenotypic variation}{subsection.3.2}% 7
\BOOKMARK [2][-]{subsection.3.3}{Cellular function of topoisomerases}{section.3}% 8
\BOOKMARK [3][-]{subsubsection.3.3.1}{Type I topoisomerases}{subsection.3.3}% 9
\BOOKMARK [3][-]{subsubsection.3.3.2}{Type II topoisomerases}{subsection.3.3}% 10
\BOOKMARK [3][-]{subsubsection.3.3.3}{Topoisomerase II poisons - Etoposide and Amsacrine}{subsection.3.3}% 11
\BOOKMARK [2][-]{subsection.3.4}{Variation in response to topoisomerase II poisons in C. elegans}{section.3}% 12
\BOOKMARK [1][-]{section.4}{Experimental Design and Methods}{}% 13
\BOOKMARK [2][-]{subsection.4.1}{Specific Aim 1 - Narrow QTL confidence intervals}{section.4}% 14
\BOOKMARK [2][-]{subsection.4.2}{Specific Aim 2 - Establish gene and variant causality}{section.4}% 15
\BOOKMARK [3][-]{subsubsection.4.2.1}{Gene causality}{subsection.4.2}% 16
\BOOKMARK [3][-]{subsubsection.4.2.2}{Identifying causal genetic variant}{subsection.4.2}% 17
\BOOKMARK [2][-]{subsection.4.3}{Specific Aim 3 - Determine molecular mechanisms }{section.4}% 18
\BOOKMARK [1][-]{section.5}{Appendix}{}% 19
